Akebia Therapeutics (AKBA) Amortization of Deferred Charges (2013 - 2020)
Akebia Therapeutics (AKBA) reported Amortization of Deferred Charges of -$647000.0 for Q1 2020, down 5.37% year-over-year from -$683748.7 in Q2 2019, and down 16.37% quarter-over-quarter from -$556000.0 in Q4 2019.
Akebia Therapeutics (AKBA) Amortization of Deferred Charges (2013 - 2020) Analysis & Trends
Akebia Therapeutics (AKBA) has 3 years of Amortization of Deferred Charges data on file, last reported at -$647000.0 in Q1 2020.
- Amortization of Deferred Charges for Q1 2020 came in at -$647000.0, down 5.37% year-over-year; the trailing twelve-month figure through Mar 2020 was -$2.3 million (down 66.58% YoY), and the FY2019 annual result was -$2.2 million, changed N/A from the prior year.
- Amortization of Deferred Charges declined to -$647000.0 in Q1 2020 per AKBA's latest filing, from -$556000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at -$483000.0 in Q2 2019 and troughed at -$647000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Akebia Therapeutics | 235.00 Mn | 72.40 Mn | 41.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -647,000.00 |
| Mar 31, 2020 | -647,000.00 |
| Dec 31, 2019 | -556,000.00 |
| Dec 31, 2019 | -556,000.00 |
| Sep 30, 2019 | -576,000.00 |
| Sep 30, 2019 | -576,000.00 |
| Jun 30, 2019 | -483,000.00 |
| Jun 30, 2019 | -483,000.00 |
| Mar 31, 2019 | -614,000.00 |
| Mar 31, 2019 | -614,000.00 |
| Dec 31, 2013 | 4,000.00 |
| Dec 31, 2013 | 4,000.00 |
| Sep 30, 2013 | -747,880.00 |
| Sep 30, 2013 | -747,880.00 |
| Mar 31, 2013 | 751,880.00 |
| Mar 31, 2013 | 751,880.00 |